Novel Therapeutic Targets

Intrinsically disordered proteins (IDPs): disease drivers up to now considered intractable by the industry.

Proprietary Technology

Our Platform allows modulating the function of IDPs by retaining their inactive, disordered state.

Unmet Medical Needs

Breakthrough treatments for incurable diseases, including cancer and beyond.